Re: Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial

BÖLEK H., KUBİLAY TOLUNAY P.

ESMO Open, cilt.10, sa.9, 2025 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 10 Sayı: 9
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1016/j.esmoop.2025.105765
  • Dergi Adı: ESMO Open
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Ankara Üniversitesi Adresli: Evet